AN2 Therapeutics
Scott Yeats has a diverse work experience spanning multiple roles and industries. Scott began their career in 2008 as a Reimbursement Consultant at AmerisourceBergen, where they worked until 2013. In 2013, they joined Myraqa, Inc. as a Clinical Trial Assistant. After a year, they moved to Illumina in 2014, initially as a Clinical Research Associate and later as a Sr. Clinical Research Associate. At Illumina, they worked until December 2022. Currently, Scott Yeats is working as a Sr. Clinical Research Associate at AN2 Therapeutics starting from December 2022.
Scott Yeats has a Bachelor of Arts degree in English from Saint Mary's College of California. Scott also possesses a certificate in Clinical Development from the San Francisco State University College of Extended Learning.
This person is not in the org chart
This person is not in any offices
AN2 Therapeutics
AN2 Therapeutics, Inc. is a biopharmaceutical company focused on bringing the power of modern biomedical and drug development expertise to provide transformational medicines for patients suffering from infectious diseases.